Correction to: Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival

Correction to: Annals of Hematology

10.1007/s00277-018-3361-2

The article Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival, written by E. Katodritou et al. 2018, was originally published electronically on the publisher’s internet portal (currently SpringerLink) on 13 May 2018 without open access.

With the author(s)’ decision to opt for Open Choice the copyright of the article changed on 26 July 2018 to ©The Author(s) 2018 and the article is forthwith distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Aside from that, the name of Eirini Katroditou should have been Eirini Katodritou.

The original article has been corrected.